Evidence map›Paper›PMID 26178038›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2016

Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.

Sharmila Dorbala, Marie Foley Kijewski, Mi-Ae Park

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden UsingJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  2. Review
  3. Significance ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  4. Nuclear imaging of cardiac amyloidosis. 'We've only just begun'.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018
    Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sharmila DorbalaDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA. sdorbala@partners.org.
Marie Foley KijewskiDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA.
Mi-Ae ParkDivision of Nuclear Medicine, Department of Radiology, Brigham and Women's Hospital, 70 Francis Street, Shapiro 5th Floor, Room 128, Boston, MA, 02115, USA.

Funding

Prognostic Utility of Absolute Coronary Microvascular Function by PET/CTK23HL092299 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DORBALA, SHARMILA · 2009 to 2013
$705k
NHLBI NIH HHS K23 HL092299
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmyloidosisHeartCardiomyopathiesHumansMagnetic Resonance ImagingMolecular Imaging

Identifiers

PMID26178038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.